Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

被引：0

作者：

Christopher N Hahn

Chan-Eng Chong

Catherine L Carmichael

Ella J Wilkins

Peter J Brautigan

Xiao-Chun Li

Milena Babic

Ming Lin

Amandine Carmagnac

Young K Lee

Chung H Kok

Lucia Gagliardi

Kathryn L Friend

Paul G Ekert

Carolyn M Butcher

Anna L Brown

Ian D Lewis

L Bik To

Andrew E Timms

Jan Storek

Sarah Moore

Meryl Altree

Robert Escher

Peter G Bardy

Graeme K Suthers

Richard J D'Andrea

Marshall S Horwitz

Hamish S Scott

机构：

[1] Centre for Cancer Biology,Department of Molecular Pathology

[2] SA Pathology,Molecular Medicine Division

[3] School of Medicine,Department of Haematology and Oncology

[4] University of Adelaide,Department of Haematology

[5] Walter and Eliza Hall Institute of Medical Research,Department of Paediatric and Reproductive Genetics

[6] The Queen Elizabeth Hospital,Cell Signalling and Cell Death Division

[7] Centre for Cancer Biology,Department of Pathology

[8] SA Pathology,Department of Medicine

[9] SA Pathology,Department of Paediatrics

[10] Walter and Eliza Hall Institute of Medical Research,undefined

[11] University of Washington School of Medicine,undefined

[12] University of Calgary,undefined

[13] SA Clinical Genetics Service,undefined

[14] SA Pathology,undefined

[15] University of Adelaide,undefined

[16] School of Molecular and Biomedical Science,undefined

[17] University of Adelaide,undefined

[18] Present addresses: Neurogenetics Laboratory,undefined

[19] Howard Florey Institute,undefined

[20] Parkville,undefined

[21] Victoria,undefined

[22] Australia (E.J.W.) and Medical Clinic,undefined

[23] Regional Hospital Emmental,undefined

[24] Burgdorf,undefined

[25] Switzerland (R.E.).,undefined

来源：

Nature Genetics | 2011年 / 43卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Hamish Scott and colleagues report that germline mutations in GATA2 segregate with myelodysplastic syndrome and acute myeloid leukemia in four pedigrees. The resulting alterations occur in a conserved zinc finger DNA-binding domain of GATA2.

引用

页码：1012 / 1017

页数：5

共 50 条

[31] GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
Yang, Li
Sun, Hanxiao
Cao, Yanan
Xuan, Binbin
Fan, Yingchao
Sheng, Huiming
Zhuang, Wenfang
PLOS ONE, 2017, 12 (01):
[32] Cooperating Transcription Factor Mutations in Acute Myeloid Leukemia (AML): Simultaneous Targeting of GATA2 and CEBPA
Greif, Philipp A.
ANNALS OF HEMATOLOGY, 2013, 92 : S40 - S41
[33] GATA2 mutations in pediatric myelodysplastic syndrome and bone marrow failure disorders
Hofmann, I.
Krasker, J.
Campagna, D.
Kierstead, D.
Schmitz-Abe, K.
Markianos, K.
Lee, M.
Sieff, C.
Williams, D. A.
Fleming, M. D.
LEUKEMIA RESEARCH, 2013, 37 : S20 - S20
[34] THE ROLE OF THE GATA2 TRANSCRIPTIONAL PROGRAM IN THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA
Gioacchino, Emanuele
de Pater, Emma
Touw, Ivo
de Looper, Hans
Strien, Paulette
Hoogenboezem, Remco
Bindels, Eric
Dzierzak, Elaine
Kaimakis, Polynikis
EXPERIMENTAL HEMATOLOGY, 2017, 53 : S104 - S104
[35] Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations
Hofmann, Inga
Avagyan, Serine
Stetson, Alyssa
Guo, Dongjing
Al-Sayegh, Hasan
London, Wendy B.
Lehmann, Leslie
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (06) : 1124 - 1130
[36] Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
Theis, F.
Corbacioglu, A.
Gaidzik, V. I.
Paschka, P.
Weber, D.
Bullinger, L.
Heuser, M.
Ganser, A.
Thol, F.
Schlegelberger, B.
Goehring, G.
Koehne, C-H
Germing, U.
Brossart, P.
Horst, H-A
Haase, D.
Goetze, K.
Ringhoffer, M.
Fiedler, W.
Nachbaur, D.
Kindler, T.
Held, G.
Luebbert, M.
Wattad, M.
Salih, H. R.
Krauter, J.
Doehner, H.
Schlenk, R. F.
Doehner, K.
LEUKEMIA, 2016, 30 (11) : 2248 - 2250
[37] High Frequency of GATA2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia with Biallelic CEBPA Mutations Identified by Exome Sequencing
Dufour, Annika
Konstandin, Nikola
Ksienzyk, Bianka
Zellmeier, Evelyn
Benthaus, Tobias
Yaghmaie, Marjan
Graf, Alexander
Krebs, Stefan
Hauser, Andreas
Blum, Helmut
Kakadia, Purvi
Schneider, Stephanie
Braess, Jan
Woermann, Bernhard Josef
Berdel, Wolfgang E.
Buechner, Thomas
Hiddemann, Wolfgang
Spiekermann, Karsten
Bohlander, Stefan K.
Greif, Philipp A.
BLOOD, 2011, 118 (21) : 35 - 35
[38] Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
F Theis
A Corbacioglu
V I Gaidzik
P Paschka
D Weber
L Bullinger
M Heuser
A Ganser
F Thol
B Schlegelberger
G Göhring
C-H Köhne
U Germing
P Brossart
H-A Horst
D Haase
K Götze
M Ringhoffer
W Fiedler
D Nachbaur
T Kindler
G Held
M Lübbert
M Wattad
H R Salih
J Krauter
H Döhner
R F Schlenk
K Döhner
Leukemia, 2016, 30 : 2248 - 2250
[39] Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A.
Kochuparambil, Samith T.
Abraham, Roshini S.
Rodriguez, Vilmarie
Howard, Matthew
Hsu, Amy P.
Jackson, Amie E.
Holland, Steven M.
Patnaik, Mrinal M.
CANCER MEDICINE, 2015, 4 (04): : 490 - 499
[40] Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype
Alfayez, Mansour
Wang, Sa A.
Banno, Sarah A.
Kontoyiannis, Dimitrios P.
Kornblau, Steven M.
Orange, Jordan S.
Mace, Emily M.
DiNard, Courtney D.
LEUKEMIA & LYMPHOMA, 2019, 60 (08) : 2025 - 2033

← 1 2 3 4 5 →